Semaglutide FDA - Search News

FDA announces end to Wegovy and Ozempic drug shortages

YAHOO!Finance · 1h

Semaglutide shortage ends as FDA sets deadline for compounders

With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions of semaglutide are no longer allowed – for now.

CNN on MSN · 2d

Ozempic and Wegovy are no longer in shortage, FDA says

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

Hosted on MSN · 2d

Ozempic and Wegovy officially moved off FDA’s drug shortage list

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration’s (FDA) drug shortage list nearly four months after the agency found the drugs to be available.

Fierce Healthcare2d

FDA declares semaglutide shortage over, spelling end to compounded GLP-1 market, for now

The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...

Compounders cast adrift after semaglutide shortage ends

The end of the official shortage status for semaglutide came as telehealth company Hims & Hers – which has been pushing sales ...

Novo Nordisk's semaglutide shortage officially concludes in the US, spelling major threat for weight loss drug compounders

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

Axios on MSN3h

Copycat Ozempic makers brace for crackdown

Makers of copycat weight-loss drugs and digital health companies that sell them are bracing for upheaval now that the Food ...

Hosted on MSN6h

Hims & Hers Retail Traders Eye Robust Post-Earnings Rebound Following Stock’s Worst Drop On Semaglutide Update

Hims & Hers Health Inc. (HIMS) stock tumbled over 25% on Friday, extending losses in after-hours trading after the U.S. Food ...

The Pharma Letter2h

Sandoz launches biosimilar Pyzchiva in USA

Swiss generics and biosimilars major Sandoz has announced the launch of Pyzchiva (ustekinumab-ttwe) in the USA. From today, ...

2dOpinion

Dying to be thin? The FDA must regulate counterfeit weight loss drugs, says AG Bonta | Opinion

More than 15.5 million Americans have tried weight loss injectables, but risks are rising with the proliferation of ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results